Feasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies
Feasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies
Darios Getahun, Iris Lin, Fagen Xie, Theresa M. Im et al.
Journal
JMIR Research Protocols
Topics
Blood groups and transfusion
article
Feasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies
Darios Getahun, Iris Lin, Fagen Xie, Theresa M. Im, Nehaa Khadka, Jiaxiao Shi, Michael J. Fassett, Sunhea Kim, Vicki Y. Chiu, Nana A. Mensah, Daniella Park, Carol Mao, Matthew Molaei
article en
Abstract
No abstract available for this paper.
Publication Tag
JMIR Research ProtocolsVol. 14
Institutions
Johnson & Johnson (United States) (US), Kaiser Permanente (US), Kaiser Permanente West Los Angeles Medical Center (US)